News

Singapore – September 20, 2026 -- Specialised Therapeutics (ST) has expanded its partnership with Incyte Biosciences International to commercialise, distribute, and register ruxolitinib cream, marketed as Opzelura, in Australia.

ST gains rights to market Opzelura for vitiligo and atopic dermatitis in Australia

Under the expanded agreement, Incyte will continue to develop and manufacture ruxolitinib cream, a topical Janus kinase (JAK) inhibitor, while ST takes on regulatory submissions, medical affairs, marketing, and distribution across the Australian market. The drug is approved in the U.S. and European Union for treating non-segmental vitiligo and mild-to-moderate atopic dermatitis in patients who do not respond adequately to standard topical therapies.

Atlanta and Carlsbad, Calif. – September 20, 2026 -- Field Medical, Inc. reported 12-month outcomes from its first-in-human Field PULSE trial showing 94.2% per-vein durability for pulmonary vein isolation using an optimized waveform, with results published in JACC: Clinical Electrophysiology and presented as a Late-Breaking Clinical Trial at HRX Live 2026.

Subsecond ablation cuts median procedure time to 13 minutes

The trial recorded a 13-minute median elapsed pulmonary vein isolation (PVI) ablation time, with a fastest case completed in 7.7 minutes. Field Medical's high-voltage focal pulsed field ablation (PFA) architecture, delivered through its FieldForce PFA System, applies energy in under 200 milliseconds per point, reducing the need for prolonged catheter stability during atrial procedures.

Atlanta and Los Angeles – September 20, 2026 -- StimCardio Medical reported that patients treated with non-invasive median nerve stimulation (MNS) after atrial fibrillation (AF) ablation showed 90.0% freedom from atrial arrhythmias at six months, compared with 80.8% for those receiving sham treatment, though the difference did not reach statistical significance. The randomized, double-blind, sham-controlled NeuroPulse pilot study was presented as late-breaking clinical science at HRX Live 2026 and simultaneously published in the peer-reviewed journal Heart Rhythm.

Post-blanking analysis finds statistically significant drop in arrhythmia events

In a sensitivity analysis conducted after the 60-day blanking period, patients receiving MNS recorded 12 recurrent atrial arrhythmia events versus 28 in the sham group, a statistically significant reduction (p=0.025). No MNS- or device-related serious adverse events were reported across the trial.

Urbandale, Iowa – September 20, 2026 -- Small businesses in the Des Moines metro should secure general liability insurance first, followed by property coverage and workers' compensation, according to insights from Ben Buenzow, an insurance expert at Buenzow Insurance Group, featured in a HelloNation article.

General liability insurance forms the first line of financial defense for small operators

The coverage protects companies against claims of bodily injury or property damage stemming from business operations, addressing risks from customers, vendors, or visitors. Legal costs and settlements tied to such claims can be significant enough to threaten a small firm's cash flow without this protection in place.

Beijing – September 20, 2026 -- Chinese President Xi Jinping has ordered sustained expansion of advanced manufacturing, calling for smart, green and integrated industrial upgrading to strengthen supply-chain self-sufficiency, according to instructions conveyed at a national conference on advanced manufacturing in Beijing reported by Xinhua News Agency.

Xi, who also chairs the Central Military Commission, said industrial chains must become more self-supporting and risk-resilient while pursuing higher-quality development and greater security. Premier Li Qiang told the conference that developing advanced manufacturing must be treated as a major strategic task.

Shanghai – – September 20, 2026 -- Ten biotech startup teams have been selected as finalists for the inaugural S2S China Symposium, narrowed from roughly 20 semifinalists who competed to pitch global venture investors at Westlake University on October 15.

RA Capital and Qiming Venture Partners co-host China chapter of Science2Startup

S2S China is the China chapter of Science2Startup, an invitation-only program founded in 2018 by F-Prime, SV Health and Atlas Venture that connects academic therapeutics researchers with biotech investors. RA Capital Management, Osage University Partners and 5AM Ventures have since joined the network. The China edition is co-hosted by RA Capital Management and Qiming Venture Partners.

Atlanta – September 20, 2026 -- Siemba has launched automated testing for insecure direct object reference (IDOR) flaws, cutting the time to scan a 200-endpoint API collection to under an hour, a task the company says has typically taken human testers days or weeks.

IDOR ranks first among OWASP's API Security Top 10 risks

IDOR, classified by OWASP as broken object level authorization, occurs when an endpoint fails to verify that a caller-supplied identifier belongs to them, allowing a single changed number in a request to expose another user's data. Siemba's Chief Security Officer Sandhya Prashanth said the flaw "drives a huge share of real-world breaches" and requires little more than systematic testing across every endpoint to detect.

New York and Suzhou, China – September 20, 2026 -- Accro Bioscience Inc. has dosed its first patient in a Phase IIb trial testing AC-101, a selective RIPK2 inhibitor, in patients with moderate-to-severe ulcerative colitis (UC).

Trial spans roughly 50 clinical sites with three treatment arms

The multicenter, double-blind, placebo-controlled study is designed across approximately 50 clinical sites and includes two AC-101 dose cohorts plus a placebo control arm. The primary endpoint is clinical remission rate at Week 12, with exploratory endpoints covering histologic remission and long-term maintenance of clinical and histologic remission.

Beijing – September 20, 2026 -- Nearly 400 domestic and international delegates gathered at the Beijing Municipal Administrative Center (BMC) on September 17 as the Beijing Green Development Forum 2026 opened, unveiling a new blue book on the capital's green economy and a standards-led transition initiative backed by more than 20 institutions.

Hosted by Asia Data Group and organized by ADG Expo Group, the forum carried the theme "Green Empowerment, Low-Carbon Symbiosis" and drew support from Global Honorary Partner Huaxia Bank and strategic partner Beijing Energy Holding Co., Ltd. International bodies including the World Green Design Organization, C40 Cities Climate Leadership Group, and the Center for China & Globalization backed the event.

Beijing – September 20, 2026 -- Nearly 390 representatives from 41 countries and regions gathered in Beijing on September 18 for the China Arbitration Summit 2026, an event that drew over 5.14 million online views from 55 countries and regions.

Four institutions co-host flagship dispute-resolution forum

The China High-level Dialogue on Maritime and Commercial Arbitration was jointly organized by the China International Economic and Trade Arbitration Commission (CIETAC), the China Maritime Arbitration Commission (CMAC), the United Nations Commission on International Trade Law (UNCITRAL), and the All China Lawyers Association (ACLA). The summit served as the flagship event of the 14th China Arbitration Week, which ran 77 seminars across 40 cities in 10 countries and regions from September 15 to 21.